参考文献/References:
[1] Montalescot G,Brieger D,Dalby AJ,et al.Duration of dual antiplatelet therapy after coronary stenting:a review of the evidence[J].J Am Coll Cardiol,2015,66(7):832-847.
[2] Hulot JS,Bura A,Villard E,et al.Cytochrome P450 2C19 loss of functionpolymorphism is a major determinant of clopidogrel responsiveness in healthy subjects[J].Blood,2006,108(7):2244-2247.
[3] Niu X,Mao L,Huang Y,et al.CYP2C19 polymorphism and clinical outcomesamong patients of different races treated with clopidogrel:A systematic reviewand meta-analysis[J].J Huazhong Univ Sci Technolog(Med Sci),2015,35(2):147-156.
[4] 何 楠,周宏灏.CYP2C19遗传多态性的研究进展[J].生理科学进展,2003,34(2):171-174.
He N,Zhou HH.The progress in CYP2C19 polymorphism research[J].Progress in Physiological Science,2003,34(2):171-174.
[5] Xiao ZS,Goldstein JA,Xie HG,et al.Differences in the incidence of theCYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han andBan populations and identification of a new rare CYP2C19 mutant allele[J].JPharmacol Experi Ther,1997,281(1):604-609.
[6] 吴 薇,韩瑞玲,王丽岳,等.DNA测序法检测C-YP2C19基因多态性指导氯吡格雷用药的临床价值[J].检验医学与临床,2015,12(4):433-435.
Wu W,Han RL,Wang LY,et al.Clinical value of DNA sequencing forCYP2C19 polymorphisms detection on the application of clopidogrel[J].Labortory Medicine and Clinic,2015,12(4):433-435.
[7] Wang Y,Chen W,Wang Y.Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention[J].Curr Cardiol Rep,2015,17(10):1-6.
[8] Osnabrugge RL,Head SJ,Zijlstra F,et al.A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users[J].Genet Med,2015,17(1):3-11.
[9] Bennis Y,Bodeau S,Bouquié R,et al.High metabolic N-oxidation of voriconazole in a patient with refractory aspergillosis and CYP2C19*17/*17 genotype[J].Br J Clin Pharmacol,2015,80(4):782-784.
[10] Pestka EL,Hale AM,Johnson BL,et al.Cytochro-me P450 testingfor better psychiatric care[J].J Psychosoc Nurs Ment Health Serv,2007,45(10):15-18.
[11] Bertilsson L.Metabolism of antidepressant and neuroleptic drugs by cytochrome p450s:clinical and interethnic aspects[J].Clin Pharmacol Ther,2007,82(5):606-609.
[12] 谭喜云,张 宇,王淑云,等. CYP2C9与CYP2C19基因多态性与癫痫患者丙戊酸血药浓度关系研究[J]. 药学与临床研究,2011,19(2):123-126.
Tan XY,Zhang Y,Wang SY,et al.Association between genetic polymorphismsof CYP2C9 and CYP2C19 and serum valproate concentration[J].Pharmaceutical and Clinical Research,2011,19(2):123-126.
[13] 顾连云,赵 萍.CYP2C19基因多态性在江苏及其周边地区汉族人群的调查研究[J].实用临床医药杂志,2011,15(1):125-128.
Gu LY,Zhao P.A study on the distribution of CY-P2C19 genetic polymorphism among han chinese in jiangsu province[J].Journal of Clinical Medicine in Practice,2011,15(1):125-128.
相似文献/References:
[1]葛高顺,倪二茹,方宜臻,等.厦门地区心血管疾病患者外周血单个核细胞CYP2C19基因型与表型的分布研究[J].现代检验医学杂志,2018,33(04):8.[doi:10.3969/j.issn.1671-7414.2018.04.003]
GE Gao-shun,NI Er-ru,FANG Yi-zhen,et al.Study on the Distribution of CYP2C19 Genotypes
and Phenotypes Mononuclear Cells of Peripheral Blood from Patients
with Cardiovascular Diseases in Xiamen Area[J].Journal of Modern Laboratory Medicine,2018,33(02):8.[doi:10.3969/j.issn.1671-7414.2018.04.003]
[2]李苗苗,王玉红,刘 静.中国沈阳地区汉族冠心病患者CYP2C19基因多态性分布特征[J].现代检验医学杂志,2019,34(02):5.[doi:10.3969/j.issn.1671-7414.2019.02.002]
LI Miao-miao,WANG Yu-hong,LIU jing.Distribution Characteristics of CYP2C19 Gene Polymorphismin Han Patients with Coronary Heart Disease in Shenyang,China[J].Journal of Modern Laboratory Medicine,2019,34(02):5.[doi:10.3969/j.issn.1671-7414.2019.02.002]